Millipore Corporation (Billerica, Massachusetts) recently announced that it has completed its acquisition of Serologicals following approval by Serologicals' shareholders last week. The acquisition will transform Millipore into a life science industry company with combined annual revenues of approximately $1.4 billion, based on 2006 full year projections.
Millipore Corporation (Billerica, Massachusetts) recently announced that it has completed its acquisition of Serologicals following approval by Serologicals' shareholders last week. The acquisition will transform Millipore into a life science industry company with combined annual revenues of approximately $1.4 billion, based on 2006 full year projections.
"The strategic combination of Millipore and Serologicals will enable us to leverage the complementary capabilities and resources of both companies," said Chairman & CEO of Millipore, Martin Madaus. "We are gaining high-value, differentiated products in important growth segments such as drug discovery products and services, nucleic function, stem cell research, and cell culture supplements. Our combined global field organization of approximately 1200 professionals, which includes some of the most technically advanced experts in the industry, will have the ability to sell a broad portfolio of innovative products and further expand our presence in emerging international markets. We now have a well-balanced growth profile between our Bioscience and Bioprocess Divisions, which will allow us to effectively execute our long-term strategy."
The combined organization of approximately 5,800 employees will also have significantly expanded R&D capabilities with more than 500 R&D professionals worldwide. With the addition of Serologicals' R&D capabilities, Millipore will be able to pursue new markets, accelerate investment in new products, and bring together the applications expertise of both companies to generate value for customers.
Sustainable Green Solvents in Microextraction: A Review of Recent Advancements
March 27th 2024Conventional sample preparation can be time- and resource-consuming, and a green analytical methodology can be a game-changer for scientists, in addition to facilitating selective and sensitive separations.
Transferring Methods to Compact and Portable HPLC
February 14th 2024The current trend in laboratory equipment design is the miniaturization of laboratory instruments. Smaller-scale HPLC instruments offer benefits that cannot be matched by analytical-scale equipment, especially in the areas of portability, reduced fluid volumes, and reduced operating costs. Yet, the miniaturization of laboratory equipment has brought with it a unique set of challenges, including transferring methods to compact LC. Capillary LC expands the use of LC to applications not currently done using conventional LC in a wide array of application areas, including pharmaceutical, food and beverage, petrochemical, environmental, and oil and gas. Greg Ward, Axcend’s CEO wrote, “Customers want an HPLC system with a small footprint, low flow rates and green chemistry.” Join his podcast where he shares method transfer in these application areas.
High-Throughput Analysis of Volatile Compounds in Air, Water, and Soil Using SIFT-MS (Apr 2024)
March 27th 2024This study demonstrates high-throughput analysis of BTEX compounds from several matrices (air, water and soil). Detection limits in the single-digit part-per-billion concentration range (by volume) are readily achievable within seconds using SIFT-MS, because sample analysis is achieved without chromatography, pre-concentration, or drying. We also present a calibration approach that enables speciation of ethylbenzene from the xylenes in real time.